Detalles de la búsqueda
1.
Methotrexate Scarcity Among Children's Oncology Group Institutions: Results of a Multinational Survey.
Oncologist
; 2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38069904
2.
Children's Oncology Group's 2023 blueprint for research: Pharmacy.
Pediatr Blood Cancer
; 70 Suppl 6: e30581, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37460409
3.
Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges.
J Oncol Pharm Pract
; 27(2): 376-388, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33334253
4.
Mycophenolate mofetil administered every 8 hours in combination with tacrolimus is efficacious in the prophylaxis of acute graft versus host disease in childhood, adolescent, and young adult allogeneic stem cell transplantation recipients.
Pediatr Blood Cancer
; 65(8): e27091, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29667720
5.
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(4): 698-704, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26785332
6.
Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement".
Biol Blood Marrow Transplant
; 26(9): e235-e236, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32531439
7.
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621.
J Clin Oncol
; 40(9): 956-967, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35007127
8.
An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients.
Biol Blood Marrow Transplant
; 16(3): 333-43, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19835971
9.
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning.
Pediatr Transplant
; 13(4): 464-74, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18785912
10.
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Bone Marrow Transplant
; 54(2): 226-235, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29899571
11.
Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation.
Pediatr Blood Cancer
; 50(2): 325-30, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17514732
12.
A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
Clin Cancer Res
; 11(7): 2644-50, 2005 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15814645
13.
Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Clin Cancer Res
; 11(19 Pt 2): 7164s-7170s, 2005 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16203817
Resultados
1 -
13
de 13
1
Próxima >
>>